UA
42
-2
MUR
27
-4
NSC
56
5
AIG
69
-2
SWKS
53
13
AMGN
28
5
CRM
49
2
KO
55
-12
DRI
58
2
CHRW
59
2
GRMN
39
-10
WU
22
-4
RSG
73
2
AEE
79
-2
APA
32
-2
PPG
50
6
THC
73
2
CPB
27
2
GIS
46
2
ETR
63
-2
UA
42
-2
MUR
27
-4
NSC
56
5
AIG
69
-2
SWKS
53
13
AMGN
28
5
CRM
49
2
KO
55
-12
DRI
58
2
CHRW
59
2
GRMN
39
-10
WU
22
-4
RSG
73
2
AEE
79
-2
APA
32
-2
PPG
50
6
THC
73
2
CPB
27
2
GIS
46
2
ETR
63
-2
Financhill
Back

Sunshine Biopharma 10K Form

Sell
22

SBFM
Sunshine Biopharma

Last Price:
$1.40
Seasonality Move:
58.97%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SBFM News And Ratings

See the #1 stock for the next 7 days that we like better than SBFM

SBFM Financial Statistics

Sales & Book Value

Annual Sales: $34.9M
Cash Flow: $-2M
Price / Cash Flow: 0
Annual Sales: $20.44
Price / Book: 0.21

Profitability

EPS (TTM): -155.32940
Net Income (TTM): $-4.2M
Gross Margin: $10.7M
Return on Equity: -18.13%
Return on Assets: -14.45%

Sunshine Biopharma Earnings Forecast

Key Sunshine Biopharma Financial Ratios

  • The Gross Profit Margin over the past 18 years for SBFM is 30.60%.
  • The Selling, General & Administrative Expenses for SBFM have been equal to 42.83% of Gross Profit Margin.
  • The Research & Development expenses have been 2.68% of Revenue.
  • The Net Earning history of SBFM is -14.72% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 8 years.

Sunshine Biopharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SBFM
Website: sunshinebiopharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.74
Quick Ratio: 3.41

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SBFM Technical Analysis vs Fundamental Analysis

Sell
22
Sunshine Biopharma (SBFM) is a Sell

Is Sunshine Biopharma a Buy or a Sell?